We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Cenkos Securities Plc | CNKS | London | Ordinary Share |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
29.00 |
Industry Sector |
---|
GENERAL FINANCIAL |
Top Posts |
---|
Posted at 26/7/2023 07:01 by quepassa Yes, I think you are missing something.The business is successful. And the future prospects for the newly-merged firm should be outstanding as the new leading independent broker. The sector is however highly cyclical. Always has been. Always will be. And players in this sector -together with their shareholders- go through periodic times of feast and famine. The recent business cycle has been dreadful for business which has lead to much reduced sector-wide profitability and a restructuring of the sector which includes the merger of Cenkos with FinnCap and the sale of Numis to Deutsche. This is a result of the near closing of the new issues and IPO market after Brexit and the bursting of the Tech sector bubble in the USA . This has hit fees hard and in turn profits and this is reflected in much lower share prices. However, there are now distinct signs that the market has bottomed and started the up-cycle phase - judging by an increasing number of IPO's both in the UK and in the USA . In these circumstances, a 3p dividend is very generous indeed. They didn't have to pay one. But more importantly, with interest rates peaking, M&A/IPO activity picking up, and an anticipated easing of UK listing regulations, the market is moving off the bottom and the future prospects for Cenkos-FinnCap should be fantastic. ALL IMO. DYOR. QP |
Posted at 25/7/2023 07:42 by quepassa Now that formal FCA clearance has been granted for the FinnCap-Cenkos merger, timetable is now slated as follows:--Revised Pay Date of juicy 3p Interim Dividend is now 6th. September. (for shareholders on the register at 11/8/23) -Old Cenkos shares to be suspended on 7th. September from 07.30hrs -New Finncap shares to start trading 8th. September effective 07.00hrs One old Cenkos share will be exchanged for 3.1942064 new FinnCap shares all imo. dyor. qp |
Posted at 14/7/2023 15:08 by arthur_lame_stocks For what it's worth I think these are worth a punt. The current market conditions won't last forever and the combination of CNKS and FCAP may be capable of making substantial profits when the market recovers. |
Posted at 01/6/2023 09:42 by its the oxman Is cnks a bargain now in the low 30s? |
Posted at 23/5/2023 09:37 by speedsgh All-share merger with finnCap approved on 17 May. Merger expected to complete in Q3 2023 following the satisfaction or waiver of the remaining conditions including the Court sanctioning the Scheme at the Scheme Sanction Hearing.Long stop date: 31/12/2023 |
Posted at 23/3/2023 09:54 by albert zog Agreed. Poor negotiation. This values CNKS at £7m ex cash. Is that all ? Dozens of clients, including Trusts. Proud legacy, including some big IPO tickets. The brand is apparently being retained. |
Posted at 23/3/2023 07:23 by albert zog Nil premium mergerInsider shareholders seem supportive Disappointing for CNKS. Share swap at very low share price levels All the rhetoric is around management preservation and co CEOs. No financial synergies disclosed. Tells you everything Current trading must be dire. FinnCap will be grateful for the CNKS cash balance |
Posted at 22/3/2023 22:25 by arthur_lame_stocks I wonder how much of the combined group CNKS shareholders will get? |
Posted at 10/3/2023 07:48 by pugugly Not looking good - Next domino to fall???????????Highlights 31-Dec-22 31-Dec-21 change Revenue £20.3m £37.2m - 46% Underlying profit (1) (2) £0.2m £4.4m - 95% (Loss) / profit before tax £(2.7)m £4.0m - 168% (Loss) / profit after tax £(2.2)m £3.4m - 165% Cash £14.2m £33.5m - £19.2m Net assets £21.8m £27.0m - £5.2m Basic earnings per share (4.9)p 7.1p Full year dividend per share paid and proposed (3) 1.5p 4.25p (1) Underlying profit is profit before the impact of the day 1 value of options and warrants received in the period and the associated fair value gains and losses on the options and warrants held, restructuring costs and costs associated with incentive plans. (2) The comparative figures have been restated to reflect the current definition of underlying profit. In the current period, in addition to adjusting for restructuring costs and costs associated with incentive plans, this is disclosed before the impact of the day one value of options and warrants received in the period and the associated fair value gains and losses on the options and warrants held. The Directors believe this provides a clearer view of the operational performance of the business in the period as their lifespan may overlap several periods before crystallisation. (3) Includes a proposed final dividend of 0.5p (2021: 3.0p) Outlook: The tough conditions of 2022 have eased slightly in the early part of 2023 but capital markets remain subdued relative to 2021. Despite this, we believe that our ongoing emphasis on working closely with clients and maintaining a proactive dialogue with investors will continue to generate opportunities and attract new clients. Our business model enables us to generate cash at an operational level and profits even in difficult market conditions and our perseverance means we are well placed as markets begin to recover. We believe our gains in market share, selective hiring of quality individuals and teams, a growing client base and a disciplined approach to costs, put us on the front foot to deliver success for our clients, colleagues and shareholders alike. |
Posted at 08/9/2022 06:26 by grahamg8 Tough times for business could translate into more takeovers and fund raising. Potentially good for CNKS. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions